Trials / Conditions / Low Risk Myelodysplastic Syndrome
Low Risk Myelodysplastic Syndrome
4 registered clinical trials studyying Low Risk Myelodysplastic Syndrome — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adult NCT04718844 | Silence Therapeutics plc | Phase 1 |
| Withdrawn | Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of NCT04176653 | Silence Therapeutics plc | Phase 1 |
| Completed | Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes NCT03824080 | GWT-TUD GmbH | Phase 2 |
| Recruiting | Pre-myeloid Cancer and Bone Marrow Failure Clinic Study NCT02958462 | Mayo Clinic | N/A |